Insider Trading History of Woodrow Adam

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Woodrow Adam since 2017. This trader's CIK number is 1639647. At the time of last reporting, Woodrow Adam was the President & Chief Commercial of Paratek Pharmaceuticals, Inc.. (stock ticker symbol PRTK). Also see all insider trading activities at Paratek Pharmaceuticals, Inc..


Yearly summary of insider trading at Paratek Pharmaceuticals, Inc. (PRTK) by Woodrow Adam

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 PRTK 0 $0 14,636 $35,651 0 $0
2021 PRTK 0 $0 50,967 $229,015 0 $0
2020 PRTK 0 $0 41,698 $260,859 0 $0
2019 PRTK 0 $0 13,054 $56,523 0 $0
2018 PRTK 0 $0 35,175 $406,239 0 $0
2017 PRTK 0 $0 3,800 $89,600 0 $0


Insider trading of Paratek Pharmaceuticals, Inc. (PRTK) by Woodrow Adam

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-12-12 PRTK Sale 3,820 1.98 7,563
2022-12-13 PRTK Sale 6,253 1.96 12,255
2022-10-28 PRTK Sale 4,563 3.47 15,833
2021-12-15 PRTK Sale 22,624 4.27 96,604
2021-12-14 PRTK Sale 10,946 4.37 47,834
2021-12-13 PRTK Sale 6,422 4.42 28,385
2021-08-17 PRTK Sale 10,975 5.12 56,192
2020-12-11 PRTK Sale 9,045 6.95 62,862
2020-12-14 PRTK Sale 12,855 6.71 86,257
2020-11-13 PRTK Sale 15,000 5.93 88,950
2020-05-12 PRTK Sale 4,798 4.75 22,790
2019-12-12 PRTK Sale 4,401 3.10 13,643
2019-10-08 PRTK Sale 5,322 3.82 20,330
2019-02-05 PRTK Sale 3,331 6.77 22,550
2018-12-12 PRTK Sale 3,733 6.76 25,235
2018-10-15 PRTK Sale 2,659 8.96 23,824
2018-10-03 PRTK Sale 8,750 9.82 85,925
2018-04-09 PRTK Sale 5,700 12.70 72,390
2018-02-05 PRTK Sale 3,333 14.22 47,395
2018-02-06 PRTK Sale 11,000 13.77 151,470
2017-07-05 PRTK Sale 3,800 23.58 89,600

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Woodrow Adam (President & Chief Commercial of Paratek Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.